Cargando…
Reply to Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease”
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617624/ http://dx.doi.org/10.1016/j.dld.2022.09.021 |
_version_ | 1784820880626417664 |
---|---|
author | Macaluso, Fabio Salvatore Orlando, Ambrogio |
author_facet | Macaluso, Fabio Salvatore Orlando, Ambrogio |
author_sort | Macaluso, Fabio Salvatore |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9617624 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96176242022-10-31 Reply to Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease” Macaluso, Fabio Salvatore Orlando, Ambrogio Dig Liver Dis Correspondence Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2023-01 2022-10-29 /pmc/articles/PMC9617624/ http://dx.doi.org/10.1016/j.dld.2022.09.021 Text en © 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Macaluso, Fabio Salvatore Orlando, Ambrogio Reply to Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease” |
title | Reply to Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease” |
title_full | Reply to Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease” |
title_fullStr | Reply to Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease” |
title_full_unstemmed | Reply to Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease” |
title_short | Reply to Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease” |
title_sort | reply to comment on: “reduced humoral response to two doses of covid-19 vaccine in patients with inflammatory bowel disease” |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617624/ http://dx.doi.org/10.1016/j.dld.2022.09.021 |
work_keys_str_mv | AT macalusofabiosalvatore replytocommentonreducedhumoralresponsetotwodosesofcovid19vaccineinpatientswithinflammatoryboweldisease AT orlandoambrogio replytocommentonreducedhumoralresponsetotwodosesofcovid19vaccineinpatientswithinflammatoryboweldisease |